CD74 expression is rather limited in normal human tissues, but it was found to be overexpressed in more than 85% of non-Hodgkin lymphoma (NHL), chronic lymphocytic leukemia (CLL) and a majority of multiple myeloma (MM) cells [8–12]. This evidence concerns the gene CD74 and B-cell chronic lymphocytic leukemia.